Gastrointestinal Symptoms Clinical Trial
Official title:
Effect of Physical Form of Apples on Gastrointestinal Function and Satiety: a MRI Study
Verified date | August 2017 |
Source | University of Nottingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Different physical form of apples had a significant effect on satiety and blood sugar levels
which was shown in a 1977 study by Haber and his team (Haber et al.1977).It was suggested
that , this effect was due to processing of the apples which modified the bioavailability of
carbohydrate and fiber content.However this was not enough to explain the mechanistic effect
of the apples. Within the last decade, the role of magenetic resonance imaging has been very
promising in understanding gastrointestinal function and physiology. Recent MRI studies have
measured changes in gastrointestinal volumes due to the effect of fermentable carbohydrates.
Apple contains fermentable carbohydrates or FODMAPs. They are known to be poorly absorbed in
the small and exert an osmotic effect by increasing markedly small bowel water content in the
intestinal lumen as demonstrated in imaging studies.(Murray et al 2014 and Placidi et al
2012). A reduction of FODMAPs in the diet of IBS sufferers has been found to alleviate
functional gut symptoms demonstrated in several randomised controlled trials.
In order to fully understand the 1977 Haber study, the investigators would like to repeat the
study using modern MRI methods in healthy volunteers and measure the volume changes in the
stomach, small bowel and colon. In addition appetite and symptoms would also be investigated
after ingesting each test meal.
Status | Completed |
Enrollment | 31 |
Est. completion date | August 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Aged 18 or older - Able to give informed consent Exclusion Criteria: - Aversion to the test product - Unable to eat whole fruit due to poor dentition or other reasons - Pregnancy and lactation declared by candidate - History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function - A positive diagnosis of irritable bowel syndrome based on the Rome III criteria questionnaire - Reported history of previous resection of the oesophagus, stomach or intestine (excluding appendix) - Intestinal stoma - Any medical condition potentially compromising participation in the study e.g. diabetes mellitus, respiratory disease limiting ability to lie in the scanner - Contraindications for MRI scanning i.e. metallic implants, pacemakers, history of metallic foreign body in eye(s) and penetrating eye injury - Unable to limit alcohol intake to = 35 units/ week and = 8 units per day during trial and to avoid alcohol the day before each study day - Unable to stop drugs known to alter GI motility including mebeverine, opiates, monoamine oxidase inhibitors, phenothiazines, benzodiazepines, calcium channel antagonists for the duration of the study (Selective serotonin reuptake inhibitors and low dose tricyclic antidepressants will be recorded but will not be an exclusion criteria) - Antibiotic or prescribed probiotic treatment in the past 8 weeks - Inability to lie flat or exceed scanner limits of weight <120kg - Poor understanding of English language - Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM - Participation in any medical trials for the past 3 months - Alteration in habitual diet in the last 6 months - Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g. cognitive dysfunction, chaotic lifestyle related to substance abuse |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Nottingham | Nottingham |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham | King's College London |
United Kingdom,
Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, Haines ML, Shepherd SJ, Gibson PR. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010 Apr;31(8):874-82. doi: 10.1111/j.1365-2036.2010.04237.x. Epub 2010 Jan 22. — View Citation
Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012 May;107(5):657-66; quiz 667. doi: 10.1038/ajg.2012.49. Epub 2012 Apr 10. Review. — View Citation
Haber GB, Heaton KW, Murphy D, Burroughs LF. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet. 1977 Oct 1;2(8040):679-82. — View Citation
Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. — View Citation
Marciani L, Wright J, Foley S, Hoad CL, Totman JJ, Bush D, Hartley C, Armstrong A, Manby P, Blackshaw E, Perkins AC, Gowland PA, Spiller RC. Effects of a 5-HT(3) antagonist, ondansetron, on fasting and postprandial small bowel water content assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2010 Sep;32(5):655-63. doi: 10.1111/j.1365-2036.2010.04395.x. — View Citation
Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ, Gibson PR. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem. 2009 Jan 28;57(2):554-65. doi: 10.1021/jf802700e. — View Citation
Murray K, Wilkinson-Smith V, Hoad C, Costigan C, Cox E, Lam C, Marciani L, Gowland P, Spiller RC. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol. 2014 Jan;109(1):110-9. doi: 10.1038/ajg.2013.386. Epub 2013 Nov 19. — View Citation
Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR, Muir JG. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73. doi: 10.1111/j.1440-1746.2010.06370.x. — View Citation
Placidi E, Marciani L, Hoad CL, Napolitano A, Garsed KC, Pritchard SE, Cox EF, Costigan C, Spiller RC, Gowland PA. The effects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea. Aliment Pharmacol Ther. 2012 Jul;36(1):64-73. doi: 10.1111/j.1365-2036.2012.05127.x. Epub 2012 May 14. — View Citation
Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013 May;108(5):707-17. doi: 10.1038/ajg.2013.96. Epub 2013 Apr 16. Review. — View Citation
Staudacher HM, Irving PM, Lomer MC, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. 2014 Apr;11(4):256-66. doi: 10.1038/nrgastro.2013.259. Epub 2014 Jan 21. Review. — View Citation
Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012 Aug;142(8):1510-8. doi: 10.3945/jn.112.159285. Epub 2012 Jun 27. — View Citation
* Note: There are 12 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Difference in symptom severity | Symptom severity measured using a visual analogue scale with a rating from 0 to 100 measured in millimeters (mm) | every 45 minutes from 0 minutes until 315 minutes for every intervention (whole apple, apple puree and apple juice) | |
Other | Difference in appetite | Appetite ratings measured using a visual analogue scale with a rating from 0 to 100 to rate fullness, satiety, hunger and desire to eat. | every 45 minutes from 0 minutes until 315 minutes for every intervention (whole apple, apple puree and apple juice) | |
Primary | Mean difference of small bowel water content (SBWC) in ml as measured by MRI from baseline to 315 minutes following ingestion of whole apple, apple puree and apple juice. | Small bowel water content will be measured in mililitres (ml) using in house software for every 45 minutes. Difference in means will be compared using repeated measure ANOVA. | every 45 minutes from 0 minutes until 315 minutes | |
Secondary | Mean difference of gastric volume measured by MRI from baseline to 315 minutes minutes following ingestion of whole apple, apple puree and apple juice. | Gastric volume in milliliters will be measured using MRI software every 45 minutes.Difference in means will be compared using repeated measure ANOVA. | every 45 minutes from 0 minutes until 315 minutes | |
Secondary | Mean breath hydrogen measured from baseline to 315 minutes | Breath hydrogen is measured in parts per million (ppm) using a breath hydrogen meter | every 45 minutes from 0 minutes until 315 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05831527 -
An Exploratory Investigation of a Supplement to Promote Gut Health
|
N/A | |
Completed |
NCT03659747 -
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Fat-free Milk
|
N/A | |
Recruiting |
NCT05972291 -
Mechanisms of Gulf War Illness
|
N/A | |
Completed |
NCT02054455 -
Proton Pump Inhibitors and Gastrointestinal Symptoms
|
Phase 4 | |
Completed |
NCT03959722 -
The Effect of Probiotics on GI Symptoms
|
N/A | |
Recruiting |
NCT03514784 -
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT01927900 -
The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers
|
N/A | |
Recruiting |
NCT04919265 -
Mother-Infant Cohort Study in Malaysia and China
|
||
Completed |
NCT01171014 -
Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms
|
Phase 2/Phase 3 | |
Completed |
NCT00574197 -
Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients
|
Phase 4 | |
Recruiting |
NCT03403387 -
Effects of GlutenShield, a Prebiotic, Probiotic, and Enzyme Supplement, on the Gut Microbiome of Adults With GI Symptoms
|
N/A | |
Completed |
NCT01964599 -
Potato Fiber and Gastrointestinal Function: Phase 3
|
N/A | |
Recruiting |
NCT06248177 -
Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).
|
N/A | |
Withdrawn |
NCT04228003 -
Pendulum D2D Glucose Control for Adults With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06425094 -
Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function
|
Phase 1 | |
Active, not recruiting |
NCT03696953 -
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.
|
Phase 2 | |
Completed |
NCT02277431 -
Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms
|
Phase 2/Phase 3 | |
Completed |
NCT00677378 -
Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain
|
N/A | |
Completed |
NCT03685552 -
Safety Evaluation of a Diet and Nutritional Supplementation Program- Purify 2.0
|
N/A | |
Completed |
NCT01184456 -
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
|
Phase 2 |